Navigation Links
NeurogesX to Hold Conference Call to Discuss Third Quarter 2009 Financial Results
Date:10/30/2009

SAN MATEO, Calif., Oct. 30 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced it will hold a conference call on Friday, November 6, 2009 at 9:00 a.m. ET (6:00 a.m. PT) to report results for its third quarter 2009.

The conference call will be hosted by Anthony DiTonno, President and Chief Executive Officer, and Stephen Ghiglieri, Chief Financial Officer.

To participate, please dial 1-877-407-0789 (USA) or 1-201-689-8562 (International). To access the live web cast please visit the Investor Relations section on the corporate web site at http://www.neurogesx.com.

A replay of the conference call will be available beginning November 6, 2009 at 7:30 p.m. ET (4:30 p.m. PT) and ending on November 16, 2009 by dialing 1-877-660-6853 (USA) or 1-201-612-7415 (International), Account Number: 3055, Conference ID Number: 336156. A replay of the webcast will also be available on the corporate website for one month, through December 6, 2009.

About NeurogesX, Inc.

NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focused on developing and commercializing novel pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza(TM), a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions. Qutenza is currently approved in the European Union for the treatmen
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NeurogesX to Present at JMP Securities Healthcare Focus Conference
2. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
3. NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
4. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
5. NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation
6. NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
7. NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
8. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
9. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
10. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
11. Beckman Coulter Announces Conference Call and Webcast of Accompanying Slides in Conjunction With Third Quarter 2009 Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , Sept. 18, 2014   Fruit Street Health ... an initial seed round of funding. ... led by a series of individual investors, the majority ... participated in the initial round are; Houston Cardiology ... Center Urologist Stacy Childs, Rapha Family Medicine Practice Owner ...
(Date:9/18/2014)... BURLINGTON, Mass. , Sept. 18, 2014  Decision ... launched anti-vascular endothelial growth factor (VEGF) agent for wet ... and Medicare Advantage plans as Genentech,s Lucentis, which is ... although surveyed managed care organization (MCO) directors do not ... Eylea is slightly more likely than Lucentis to be ...
(Date:9/18/2014)... , Sept. 18, 2014  A $3 million grant ... the University of Michigan to establish a national center ... Glenn Center for Aging Research at U-M will focus ... can slow the effects of aging and postpone diseases ... aging that can help develop medications that may help ...
Breaking Medicine Technology:Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 2Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 3Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 2Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 3$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 2$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 3
... April 25, 2011 The ophthalmic therapeutics company Xcovery ... and CEO, and Dr. Ken Mandell, President and COO, ... Vision and Ophthalmology (ARVO) Annual Meeting in Fort Lauderdale ... of a Serial Entrepreneur recounts his repeated success ...
... April 25, 2011 The 2010 Pharmacy Today ... American Pharmacists Association , reveals pharmacists believe that ... was recommended by their pharmacist, 92% of pharmacists walk ... a product selection and the average patient consult takes ...
Cached Medicine Technology:Xcovery Vision Founders to Speak at ARVO 2011 2Pharmacists Offer Guidance on Top Over-The-Counter Medications 2Pharmacists Offer Guidance on Top Over-The-Counter Medications 3
(Date:9/18/2014)... "Medical staff need better ways to provide quick ... privacy," said one of two inventors from Hialeah, Fla. ... supply caregivers with the equipment they need to do ... The Helper to make it easier to reposition a ... his or her side. It also securely stabilizes the ...
(Date:9/18/2014)... 2014 It’s been just a few short ... pending bunion splint to website visitors, but already the response ... was absolutely delighted. It is perfect and I find it ... them. THANK YOU FOR LISTENING!!!" Another user compared the ... hole used to slip to the end of my toe. ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Companies in ... refine carbon dioxide, selling it to downstream industries in ... for carbon dioxide are food and beverage manufacturers. Food ... as fruits, vegetables or pizzas. The gas is also ... use the compound to carbonate soft drinks, beer and ...
(Date:9/18/2014)... HealthDay Reporter , THURSDAY, Sept. 18, ... waiting times, patients seeking care at larger urban hospitals are ... those seen at smaller or more rural facilities, new research ... provide timely emergency care varies dramatically across hospitals in the ... research, Dr. Renee Hsia, an associate professor at the University ...
(Date:9/18/2014)... Sept. 18, 2014 (HealthDay News) -- Daily supplements of ... against the development of age-related cataracts among men, a ... that one or both could help prevent cataracts. To ... Hospital and Harvard Medical School in Boston, and his ... selenium and vitamin E. The trial was initially designed ...
Breaking Medicine News(10 mins):Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 3Health News:Carbon Dioxide Production in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Carbon Dioxide Production in the US Industry Market Research Report Now Available from IBISWorld 3Health News:ER Waiting Times Vary Significantly, Studies Find 2Health News:ER Waiting Times Vary Significantly, Studies Find 3Health News:Vitamin E, Selenium Supplements Don't Seem to Prevent Cataracts 2
... MONDAY, Oct. 17 (HealthDay News) -- For years, nutritionists ... eat." Now, new research suggests this adage might even ... observation stems from a pair of studies slated for presentation ... in Orlando, Fla., both of which highlight an apparent linkage ...
... MASS. October 17, 2011 The Institute for ... announced Sharon K. Inouye, M.D., M.P.H., has been elected ... independent, nonprofit organization that works outside of government to ... the public. Inouye is the Director of the ...
... HealthDay Reporter , MONDAY, Oct. 17 (HealthDay News) ... candy and some medications, teachers are almost as likely to ... by two enterprising elementary schoolers. Casey Gittelman, who,s ... a special medicine cabinet filled with medicine and candies to ...
... is available in French and Spanish . ... than other women. Furthermore, the likelihood of developing breast cancer is ... of the main conclusions drawn in an article recently published in ... Granada research group CTS 367, coordinated by the Nursery Department professor ...
... Jenifer Goodwin HealthDay Reporter , SATURDAY, Oct. 15 ... hospital emergency departments don,t believe their weight poses a risk ... them otherwise, a new study finds. Researchers asked 450 ... at Shands at the University of Florida two questions: Do ...
... HealthDay Reporter , MONDAY, Oct. 17 (HealthDay News) -- Is ... so, says a new study that finds a link between ... However, the research doesn,t confirm that exposure to trash-talking ... explain why non-aggressive cussing might be a bad thing. And ...
Cached Medicine News:Health News:Healthier Diet, Stronger Sperm? 2Health News:Healthier Diet, Stronger Sperm? 3Health News:Hebrew SeniorLife's Dr. Sharon K. Inouye elected to Institute of Medicine 2Health News:It's Easy to Mistake Medicine for Candy 2Health News:It's Easy to Mistake Medicine for Candy 3Health News:Obese women have higher risk of suffering breast cancer 2Health News:Many Don't Believe Their Obesity is Unhealthy: Study 2Health News:Many Don't Believe Their Obesity is Unhealthy: Study 3Health News:Many Don't Believe Their Obesity is Unhealthy: Study 4Health News:Profanity on TV Linked to Foul-Mouthed Kids 2
... for Candida albicans in only five ... two enzyme color reactions to produce ... read. AlbiQuicktm is performed on a ... Incubation time is only five minutes ...
... for small and large multi-specialty provider networks. ... check-out. Review the complete Patient History, from ... labs and charts all by one click ... immediately. Communicate electronically with the referring physicians ...
... meridianEMR is a revolutionary "blended model EMR ... medical records in your office and on-line ... of physicians and software engineers, meridianEMR combines ... create a highly modular medical EMR that ...
... an Automated Digital Cell Morphology and Informatics ... and transmission of White & Red Blood ... blood smears can be loaded at once, ... 60 per hour depending on the tests ...
Medicine Products: